GNTA
Genenta Science (GNTA)
$87
About Genenta Science (GNTA)
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Details
Daily high
$2.07
Daily low
$1.86
Price at open
$1.86
52 Week High
$10.00
52 Week Low
$1.35
Market cap
35.8M
Dividend yield
0.00%
Volume
30,231
Avg. volume
106,438
P/E ratio
-3.66
Genenta Science News
Details
Daily high
$2.07
Daily low
$1.86
Price at open
$1.86
52 Week High
$10.00
52 Week Low
$1.35
Market cap
35.8M
Dividend yield
0.00%
Volume
30,231
Avg. volume
106,438
P/E ratio
-3.66